v3.22.0.1
CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Non-Controlling Interest
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-redeemable Non-Controlling Interests
Beginning balance at Dec. 31, 2018     $ 0 $ 14,177              
Beginning balance (in shares) at Dec. 31, 2018       903,607              
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Vesting and exercise of warrants (in shares)       923              
Vesting and exercise of warrants       $ 45              
Lapsing of repurchase option related to Series E redeemable convertible preferred stock issued to a non-employee service provider $ 10     $ 2   $ 10          
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)       (904,530) 904,530            
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 14,224     $ (14,224)   14,224          
Issuance of non-controlling interests 667   333               $ 667
Net income (loss)     (22)                
Ending balance (in shares) at Dec. 31, 2019       0              
Ending balance at Dec. 31, 2019     311 $ 0              
Beginning balance (in shares) at Dec. 31, 2018         457,189            
Beginning balance at Dec. 31, 2018 (7,385) $ 9     $ 0 668   $ (188) $ (7,865) $ 9 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Lapsing of repurchase option related to Series E redeemable convertible preferred stock issued to a non-employee service provider 10     $ 2   10          
Conversion of warrant to common stock in connection with initial public offering (in shares)         150            
Conversion of warrant to common stock in connection with initial public offering 7         7          
Conversion of convertible notes to common stock in connection with public offering (in shares)         93,978            
Conversion of convertible notes to common stock in connection with initial public offering 4,229         4,229          
Repurchase of outstanding shares (in shares)         (1)            
Exercise of stock options (in shares)         6,924            
Exercise of stock options 21         21          
Exercise of put option on common stock held by Yandex (in shares)         (1,528)            
Exercise of put option on common stock held by Yandex (47)         (47)          
Repurchase of unvested early-exercised stock options (in shares)         (32)            
Stock-based compensation 4,634         4,634          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)         2,076            
Issuance of common stock under the Employee Stock Purchase Plan 49         49          
Issuance of common stock in connection with initial public offering, net of offering cost (in shares)         180,000            
Issuance of common stock in connection with initial public offering, net of offering costs 7,973         7,973          
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)       (904,530) 904,530            
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 14,224     $ (14,224)   14,224          
Issuance of common stock related to private placement (in shares)         11,111            
Issuance of common stock in private placement 500         500          
Issuance of common stock for settlement of RSUs (in shares)         98,328            
Shares withheld related to net share settlement (in shares)         (36,249)            
Shares withheld related to net share settlement (1,573)         (1,573)          
Reclassification of share-based award liability to additional paid-in capital 21         21          
Repayment of employee loans collateralized by outstanding common stock 14         14          
Issuance of common stock as consideration for investment and acquisition (in shares)         205            
Issuance of common stock as consideration for investment and acquisition 9         9          
Issuance of non-controlling interests 667   333               667
Unrealized gain on investments in available-for-sale securities, net of tax 4             4      
Foreign currency translation adjustment (3)             (3)      
Net income (loss) (8,491)               (8,506)   15
Ending balance (in shares) at Dec. 31, 2019         1,716,681            
Ending balance at Dec. 31, 2019 $ 14,872       $ 0 30,739   (187) (16,362)   682
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Issuance of non-controlling interests     247                
Recognition of non-controlling interest upon acquisition     290                
Net income (loss)     (52)                
Ending balance at Dec. 31, 2020     787                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                    
Exercise of stock options (in shares)         16,821            
Exercise of stock options $ 80         80          
Stock-based compensation 861         861          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)         4,934            
Issuance of common stock under the Employee Stock Purchase Plan 125         125          
Equity component of convertible notes, net 243         243          
Issuance of common stock as consideration for acquisitions (in shares)         73,396            
Issuance of common stock as consideration for acquisitions 3,898         3,898          
Issuance of common stock for settlement of RSUs (in shares)         38,476            
Shares withheld related to net share settlement (in shares)         (555)            
Shares withheld related to net share settlement (17)         (17)          
Release of shares previously held in escrow related to prior business combination (in shares)         41            
Release of shares previously held in escrow related to prior business combination 2         2          
Issuance of non-controlling interests     247                
Unrealized gain on investments in available-for-sale securities, net of tax 2             2      
Foreign currency translation adjustment (350)             (350)      
Distributions to non-controlling interests (13)   (9)               (13)
Net income (loss) $ (6,736)               (6,768)   32
Ending balance (in shares) at Dec. 31, 2020 1,849,794       1,849,794            
Ending balance at Dec. 31, 2020 $ 12,967 $ (243)     $ 0 35,931 $ (243) (535) (23,130)   701
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Re-measurement of non-controlling interest (1,058)   1,052     (1,058)          
Acquisition of non-controlling interests     (1,194)                
Derecognition of non-controlling interests upon divestiture (701)   (356)               (701)
Net income (loss)     (85)                
Ending balance at Dec. 31, 2021     $ 204                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of stock options (in shares)         9,440            
Exercise of stock options 101         101          
Stock-based compensation 1,204         1,204          
Issuance of common stock under the Employee Stock Purchase Plan (in shares)         2,770            
Issuance of common stock under the Employee Stock Purchase Plan 107         107          
Issuance of common stock as consideration for acquisitions (in shares)         19,377            
Issuance of common stock as consideration for acquisitions 929         929          
Issuance of common stock for settlement of Careem Convertible Notes (in shares)         4,225            
Issuance of common stock for settlement of Careem Convertible Notes $ 232         232          
Issuance of common stock for settlement of contingent consideration liability (in shares) 2,252                    
Issuance of common stock for settlement of contingent consideration liability $ 102         102          
Issuance of restricted stock awards, subject to repurchase, in connection with acquisition of non-controlling interest (in shares)         4,641            
Recognition of non-controlling interest upon acquisition (in shares)         20,641            
Acquisition of non-controlling interests 1,327         1,327          
Recognition of non-controlling interest upon sale of Freight Holding preferred stock 675                   675
Issuance of common stock for settlement of RSUs (in shares)         36,703            
Shares withheld related to net share settlement (in shares)         (527)            
Shares withheld related to net share settlement (28)         (28)          
Reclassification of share-based award liability to additional paid-in capital 4         4          
Unrealized gain on investments in available-for-sale securities, net of tax (46)             (46)      
Foreign currency translation adjustment 57             57      
Net income (loss) $ (484)               (496)   12
Ending balance (in shares) at Dec. 31, 2021 1,949,316       1,949,316            
Ending balance at Dec. 31, 2021 $ 15,145       $ 0 $ 38,608   $ (524) $ (23,626)   $ 687